(Total Views: 724)
Posted On: 09/26/2021 11:53:15 PM
Post# of 154968
The expiration of the product patent is actually 2024 (2023 is Australian patent).
https://patents.google.com/patent/US200302283...amp;page=1
One of the things with FDA marketing exclusivity is that slightly before the 12 years is up a generics manufacturer can apply for and get all manufacturing information from the original company. While wading through the Cytodyn patents I realized there was no patent on manufacturing for leronlimab. It may be possible to get such a patent (if any novelty can be proved) which would block anyone else from manufacturing leronlimab for 20 years.
Anyone with good contacts at the company feel free to pass this on.
https://patents.google.com/patent/US200302283...amp;page=1
One of the things with FDA marketing exclusivity is that slightly before the 12 years is up a generics manufacturer can apply for and get all manufacturing information from the original company. While wading through the Cytodyn patents I realized there was no patent on manufacturing for leronlimab. It may be possible to get such a patent (if any novelty can be proved) which would block anyone else from manufacturing leronlimab for 20 years.
Anyone with good contacts at the company feel free to pass this on.
(8)
(1)
